- Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea
-
Hong YM, Yoon KT, Park YJ, Woo HY, Heo J
- KMID: 2545546
- J Korean Med Sci.
- 2023 Aug;38(34):e270.
- doi: 10.3346/jkms.2023.38.e270
Background This study aimed to investigate the prevalence rate of hepatitis C virus (HCV) infection and identify the demographic, and sociological characteristics and changes in awareness of HCV infection by participating... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute hepatitis C virus infection: clinical update and remaining challenges
-
Liu CH, Kao JH
- KMID: 2543984
- Clin Mol Hepatol.
- 2023 Jul;29(3):623-642.
- doi: 10.3350/cmh.2022.0349
Acute hepatitis C virus (HCV) infection is a global health concern with substantial geographical variation in the incidence rate. People who have received unsafe medical procedures, used injection drugs, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
-
Kim KA, Lee S, Park HJ, Jang ES, Lee YJ, Cho SB, Kim YS, Kim IH, Lee BS, Chung WJ, Ahn SH, Kim S, Jeong SH
- KMID: 2541438
- Clin Mol Hepatol.
- 2023 Apr;29(2):496-509.
- doi: 10.3350/cmh.2022.0345
Background/Aims: We used next-generation sequencing (NGS) to analyze resistance-associated substitutions (RASs) and retreatment outcomes in patients with chronic hepatitis C virus (HCV) infection who failed direct-acting antiviral agent (DAA) treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Report on the External Quality Assessment Scheme for Molecular Microbiology, Hepatitis Virus 1, 2 (2016–2021)
-
Moon HW, Lee TH, Seo JD
- KMID: 2538677
- Lab Med Qual Assur.
- 2022 Dec;44(4):191-198.
- doi: 10.15263/jlmqa.2022.44.4.191
The clinical demand for molecular tests is increasing and thus, the need for quality control is also increasing. The Korean Association of External Quality Assessment Service has operated a test... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study
-
Lee SK, Lee SW, Lee HL, Kim HY, Kim CW, Song DS, Chang UI, Yang JM, Yoo SH, Kwon JH, Nam SW, Kim SH, Song MJ, Lee J, Yang H, Bae SH, Han JW, Nam H, Sung PS, Jang JW, Choi JY, Yoon SK
- KMID: 2535982
- Korean J Intern Med.
- 2022 Nov;37(6):1167-1175.
- doi: 10.3904/kjim.2022.013
Background/Aims: To evaluate the efficacy and safety of ledipasvir/sofosbuvir (LDV/SOF) therapy in hepatitis C virus (HCV)-infected Korean patients in a real clinical setting. Methods: A total of 273 patients who received... -
- CITED
-
- Close
- SHARE
-
- Close
- The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment
-
Choi J, Park J, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Chung YH
- KMID: 2535199
- Gut Liver.
- 2022 Nov;16(6):964-975.
- doi: 10.5009/gnl210416
Background/Aims: The care cascade for hepatitis C virus (HCV) infection is impeded by multiple barriers, including suboptimal anti-HCV testing, link to care, and diagnosis. We explored the changes in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features of Hepatitis C Virus-related Acute-on-chronic Liver Failure in a Korean Population
-
Choi JW, Kwak JY, Lee SS, Kim Hg, Son HJ, Jeon H, Kim HJ, Cha RR, Lee JM, Kim HJ
- KMID: 2534465
- Korean J Gastroenterol.
- 2022 Oct;80(4):169-176.
- doi: 10.4166/kjg.2022.050
Background/Aims: Acute-on-chronic liver failure (ACLF) is a widely recognized concept in which acute decompensation (AD) in patients with cirrhosis results in organ failure and high short-term mortality. On the other... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
-
Park MS, Yang YM, Park KH, Yoon H, Kim JS, Choi EJ
- KMID: 2533899
- Korean J Clin Pharm.
- 2022 Sep;32(3):191-203.
- doi: 10.24304/kjcp.2022.32.3.191
Background: Direct-acting antivirals are recommended for the treatment of chronic hepatitis C virus in Korea. However, evaluation of direct-acting antiviral regimens in a real-world setting is limited. The aims of... -
- CITED
-
- Close
- SHARE
-
- Close
- A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
-
Kim HL, Kim KA, Choi GH, Jang ES, Ki M, Choi HY, Jeong SH
- KMID: 2523874
- Clin Mol Hepatol.
- 2022 Jan;28(1):91-104.
- doi: 10.3350/cmh.2021.0236
Background/Aims: This study aimed to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening compared to no screening in the Korean population from societal and healthcare system perspectives. Methods: A published... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials
-
Heo J, Kim YJ, Lee JW, Kim JH, Lim YS, Han KH, Jeong SH, Cho M, Yoon KT, Bae SH, Crown ED, Fredrick LM, Alami NN, Asatryan A, Kim DH, Paik SW, Lee YJ
- KMID: 2522351
- Gut Liver.
- 2021 Nov;15(6):895-903.
- doi: 10.5009/gnl20321
Background/Aims: Glecaprevir/pibrentasvir (G/P) is the first pan-genotypic direct-acting antiviral combination therapy approved in Korea. An integrated analysis of five phase II and III trials was conducted to evaluate the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
-
Lim DH, Jeong JY, Nam S, Choi J, Kwon HC, Yoon YB, Kim Y, Chin B
- KMID: 2522883
- J Korean Med Sci.
- 2021 Nov;36(46):e308.
- doi: 10.3346/jkms.2021.36.e308
Background: Because of the very low incidence of human immunodeficiency virus (HIV) coinfection in Korea, data on hepatitis C virus (HCV)/HIV coinfection are limited. This study aimed to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Test Parameters on the Performance of Rapid Anti-Hepatitis C Virus Immunochromatographic Assay
-
Choi EJ, Kim JH, Han MS
- KMID: 2514600
- Lab Med Qual Assur.
- 2021 Mar;43(1):37-42.
- doi: 10.15263/jlmqa.2021.43.1.37
Anti-hepatitis C virus (HCV) immunochromatographic assay (ICA) is commonly used as an early screening test for HCV infection. This study evaluated the influence of test parameters (technician, assay type, kit... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area
-
Shin J, Yu JH, Jin YJ, Lee JW
- KMID: 2514233
- J Liver Cancer.
- 2021 Mar;21(1):34-44.
- doi: 10.17998/jlc.21.1.34
Background/objective: Hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) is rarely observed in patients without liver cirrhosis (LC). We evaluated the incidence and clinical feature of HCV-associated HCC patients with or... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiological and Clinical History of Viral Hepatitis in Korea
-
Yoon JH, Cho SH, Kim DY, Yu SJ, Han KH
- KMID: 2514846
- Infect Chemother.
- 2021 Mar;53(1):159-165.
- doi: 10.3947/ic.2021.0300
Viral hepatitis is the most important cause of acute and chronic liver disease in Korea. Particularly, hepatitis B virus (HBV) is the leading cause of liver-related mortality. Because of the nationwide... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
-
Kwan BS, Kim JH, Park SJ, Choe WH, Kwon SY, Yoo BC
- KMID: 2513740
- Korean J Intern Med.
- 2021 Mar;36(2):292-304.
- doi: 10.3904/kjim.2019.297
Background/Aims: Chronic hepatitis C (CHC) treatment has dramatically improved since direct-acting antiviral (DAA) therapy was introduced. However, the use of DAA therapy in CHC patients with hepatocellular carcinoma (HCC) remains... -
- CITED
-
- Close
- SHARE
-
- Close
- A Healthcare-Associated Outbreak of HCV Genotype 2a at a Clinic in Seoul
-
Choi S, Lee H, Lee H, Chung YS
- KMID: 2513221
- Osong Public Health Res Perspect.
- 2021 Feb;12(1):3-12.
- doi: 10.24171/j.phrp.2021.12.1.02
Objectives: An epidemiological investigation was conducted into a hepatitis C virus (HCV) outbreak at an outpatients clinic in Seoul (2011-2012). The aim of the study was to analyze the scale... -
- CITED
-
- Close
- SHARE
-
- Close
- Relation between Lichen Planus and Hepatitis C Virus Infection
-
Park JB, Seong SH, Lee KH, Suh KS, Yu BC, Jang MS
- KMID: 2509668
- Korean J Dermatol.
- 2020 Dec;58(10):662-668.
Background: The etiology and pathogenesis of lichen planus (LP) are not fully understood. Several studies have reported varying prevalence of anti-hepatitis C virus antibody (anti-HCV Ab) in LP. The relationship... -
- CITED
-
- Close
- SHARE
-
- Close
- Performance Evaluations of the Abbott Alinity m Assay in Comparison with the Abbott m2000 Assay for Hepatitis B and Hepatitis C Viruses
-
Yoo J, Son BS, Han E, Yu GG, Lee S
- KMID: 2506967
- Lab Med Qual Assur.
- 2020 Sep;42(3):150-155.
- doi: 10.15263/jlmqa.2020.42.3.150
ackground: The quantification of the hepatitis B virus (HBV) or hepatitis C virus (HCV) is critical for the diagnosis and prognostic follow-up of the viral infection. The Alinity m assay... -
- CITED
-
- Close
- SHARE
-
- Close
- Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
-
Huang CF, Yu ML
- KMID: 2504498
- Clin Mol Hepatol.
- 2020 Jul;26(3):251-260.
- doi: 10.3350/cmh.2020.0018
The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can be provided by novel... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
-
Seo JW, Kwan BS, Cheon YK, Lee TY, Shim CS, Kwon SY, Choe WH, Yoo BC, Yoon JM, Lee JH
- KMID: 2502048
- Korean J Intern Med.
- 2020 May;35(3):566-573.
- doi: 10.3904/kjim.2018.062
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is the second-most common primary liver malignancy, arising from the peripheral intrahepatic bile duct epithelium. Hepatitis B virus (HBV) or hepatitis C virus (HCV) may be... -
- CITED
-
- Close
- SHARE
-
- Close
